Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Nexentis Technologies Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 6 | 12 | +6 |
| Shares | 184.0K | 416.1K | +232.1K (+126.2%) |
| Value | $622.0K | $790.0K | +$168.0K (+27.0%) |
New holders (6)
Institutions that held Nexentis Technologies Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 151,392 | $288.0K | 0.01% |
| Psagot Value Holdings Ltd. / (Israel) | 30,000 | $57.0K | 0.02% |
| Jane Street Group, LLC | 25,252 | $48.0K | 0.00% |
| Susquehanna International Group, LLP | 11,703 | $22.0K | 0.00% |
| Warberg Asset Management LLC | 10,000 | $19.0K | 0.01% |
| Wells Fargo & Company | 17 | $0 | 0.00% |
Sold out (0)
Institutions that held Nexentis Technologies Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.